Home
Conditions
Respiratory Hypersensitivity

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,455 public trials 324 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With Asthma

NCT03108027

Conditions: Asthma, Bronchial Diseases, Dyspnea, +11 more
Locations: Novartis Investigative Site Berlin, Germany

Novartis Investigative Site Frankfurt Am Main Hessen, Germany

Novartis Investigative Site Großhansdorf, Germany

Novartis Investigative Site Hanover, Germany

View Trial Details

Completed

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma

NCT03574805

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Q-Pharm Herston, Queensland, Australia

CMAX Adelaide, South Australia, Australia

Nucleus Network Limited Melbourne, Victoria, Australia

Linear Nedlands, Western Australia, Australia

View Trial Details

Completed

Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With Asthma

NCT04678063

Conditions: Allergic Asthma, Allergy, Allergy to Cats, +9 more
Locations: Alyatec Strasbourg, Grand Est, France

View Trial Details

Completed

To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma

NCT01568762

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Novartis Investigative Site Raleigh, North Carolina, United States

View Trial Details

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients

NCT00940160

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Novartis Investigator Site Moscow, Russia

Novartis Investigator Site Saint Petersburg, Russia

Novartis Investigator Site Manchester, United Kingdom

View Trial Details

Completed

Efficacy of QAX576 in Asthma

NCT01130064

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Novartis Investigative Site Phoenix, Arizona, United States

Novartis Investigative Site Huntington Beach, California, United States

Novartis Investigative Site Owensboro, Kentucky, United States

Novartis Investigative Site Wheaton, Maryland, United States

View all 52 locations

View Trial Details

Completed

Evaluation of the Efficacy of Pirfenidone in Progressive Chronic Hypersensitivity Pneumonitis

NCT04675619

Conditions: Alveolitis, Extrinsic Allergic, Hypersensitivity, Hypersensitivity Pneumonitis, +6 more
Locations: Eman Shebl Zagazig, Egypt

View Trial Details

Completed

Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma

NCT00624702

Conditions: Asthma, Bronchial Diseases, Cough, +11 more
Locations: Novartis Investigator Site Ottawa, Ontario, Canada

Novartis Investigator Site Montreal, Quebec, Canada

View Trial Details

Completed

Efficacy, Safety, and Pharmacokinetics of QAW039

NCT01253603

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations: Novartis Investigative Site Encinitas, California, United States

Novartis Investigative Site Huntington Beach, California, United States

Novartis Investigative Site Los Angeles, California, United States

Novartis Investigative Site Los Angeles, California, United States

View all 26 locations

View Trial Details

Completed

Study and Development of Application Models of "Therapeutic Education to the Patient" (TEP) in Asthmatic Children

NCT02636920

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council Palermo, Sicily, Italy

View Trial Details

Respiratory Hypersensitivity

Respiratory Hypersensitivity trial results

Related conditions